Literature DB >> 32178774

COVID-19, ECMO, and lymphopenia: a word of caution.

Brandon Michael Henry1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32178774      PMCID： PMC7118650          DOI： 10.1016/S2213-2600(20)30119-3

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  5 in total

1.  Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults.

Authors:  Matthew J Bizzarro; Steven A Conrad; David A Kaufman; Peter Rycus
Journal:  Pediatr Crit Care Med       Date:  2011-05       Impact factor: 3.624

2.  Continuous renal replacement therapy reduces the systemic and pulmonary inflammation induced by venovenous extracorporeal membrane oxygenation in a porcine model.

Authors:  Jialiang Shi; Qiyi Chen; Wenkui Yu; Juanhong Shen; Jianfeng Gong; Changsheng He; Yiming Hu; Juanjuan Zhang; Tao Gao; Fengchan Xi; Jieshou Li
Journal:  Artif Organs       Date:  2013-12-11       Impact factor: 3.094

3.  Interleukin-6 may predict survival in extracorporeal membrane oxygenation treatment.

Authors:  I Risnes; K Wagner; T Ueland; Te Mollnes; P Aukrust; Jl Svennevig
Journal:  Perfusion       Date:  2008-05       Impact factor: 1.972

4.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.

Authors:  Xiaobo Yang; Yuan Yu; Jiqian Xu; Huaqing Shu; Jia'an Xia; Hong Liu; Yongran Wu; Lu Zhang; Zhui Yu; Minghao Fang; Ting Yu; Yaxin Wang; Shangwen Pan; Xiaojing Zou; Shiying Yuan; You Shang
Journal:  Lancet Respir Med       Date:  2020-02-24       Impact factor: 30.700

5.  Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.

Authors:  Qiurong Ruan; Kun Yang; Wenxia Wang; Lingyu Jiang; Jianxin Song
Journal:  Intensive Care Med       Date:  2020-03-03       Impact factor: 17.440
  5 in total
  94 in total

1.  Update of the recommendations of the Sociedade Portuguesa de Cuidados Intensivos and the Infection and Sepsis Group for the approach to COVID-19 in Intensive Care Medicine.

Authors:  João João Mendes; José Artur Paiva; Filipe Gonzalez; Paulo Mergulhão; Filipe Froes; Roberto Roncon; João Gouveia
Journal:  Rev Bras Ter Intensiva       Date:  2022-01-24

Review 2.  COVID-19 and Extracorporeal Membrane Oxygenation.

Authors:  Gennaro Martucci; Artur Słomka; Steven Eric Lebowitz; Giuseppe Maria Raffa; Pietro Giorgio Malvindi; Valeria Lo Coco; Justyna Swol; Ewa Żekanowska; Roberto Lorusso; Waldemar Wierzba; Piotr Suwalski; Mariusz Kowalewski
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Epidemiology and Etiopathogeny of COVID-19.

Authors:  Modesto Leite Rolim Neto; Claúdio Gleidiston Lima da Silva; Maria do Socorro Vieira Dos Santos; Estelita Lima Cândido; Marcos Antônio Pereira de Lima; Sally de França Lacerda Pinheiro; Roberto Flávio Fontenelle Pinheiro Junior; Claudener Souza Teixeira; Sávio Samuel Feitosa Machado; Luiz Fellipe Gonçalves Pinheiro; Grecia Oliveira de Sousa; Lívia Maria Angelo Galvão; Karla Graziely Soares Gomes; Karina Alves Medeiros; Luana Araújo Diniz; Ítalo Goncalves Pita de Oliveira; Jéssica Rayanne Pereira Santana; Maria Aline Barroso Rocha; Irving Araújo Damasceno; Thiago Lima Cordeiro; Wendell da Silva Sales
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Eleven routine clinical features predict COVID-19 severity uncovered by machine learning of longitudinal measurements.

Authors:  Kai Zhou; Yaoting Sun; Lu Li; Zelin Zang; Jing Wang; Jun Li; Junbo Liang; Fangfei Zhang; Qiushi Zhang; Weigang Ge; Hao Chen; Xindong Sun; Liang Yue; Xiaomai Wu; Bo Shen; Jiaqin Xu; Hongguo Zhu; Shiyong Chen; Hai Yang; Shigao Huang; Minfei Peng; Dongqing Lv; Chao Zhang; Haihong Zhao; Luxiao Hong; Zhehan Zhou; Haixiao Chen; Xuejun Dong; Chunyu Tu; Minghui Li; Yi Zhu; Baofu Chen; Stan Z Li; Tiannan Guo
Journal:  Comput Struct Biotechnol J       Date:  2021-06-17       Impact factor: 7.271

5.  Continuous venous hemodialysis integrated to the ECMO circuit in critically ill patient with COVID-19, a case report in Morocco.

Authors:  Anass Mounir; Saara Lamghari; Amine Raja; Khalil Allali; Sara Chebbar; Basma Buri; Yasmine Mahdar; Chafik El Kettani; Benyounes Ramdani; Youssef Ettaoumi; Ghali Benouna; Lahoucine Barrou
Journal:  Pan Afr Med J       Date:  2020-08-10

6.  Computational pathology reveals unique spatial patterns of immune response in H&E images from COVID-19 autopsies: preliminary findings.

Authors:  Germán Corredor; Paula Toro; Kaustav Bera; Dylan Rasmussen; Vidya Sankar Viswanathan; Christina Buzzy; Pingfu Fu; Lisa M Barton; Edana Stroberg; Eric Duval; Hannah Gilmore; Sanjay Mukhopadhyay; Anant Madabhushi
Journal:  J Med Imaging (Bellingham)       Date:  2021-07-13

7.  Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19.

Authors:  Yun Tan; Wei Zhang; Zhaoqin Zhu; Niu Qiao; Yun Ling; Mingquan Guo; Tong Yin; Hai Fang; Xiaoguang Xu; Gang Lu; Peipei Zhang; Shuangshuang Yang; Ziyu Fu; Dongguo Liang; Yinyin Xie; Ruihong Zhang; Lu Jiang; Shuting Yu; Jing Lu; Fangying Jiang; Jian Chen; Chenlu Xiao; Shengyue Wang; Shuo Chen; Xiu-Wu Bian; Hongzhou Lu; Feng Liu; Saijuan Chen
Journal:  Cell Discov       Date:  2021-06-08       Impact factor: 10.849

8.  Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2.

Authors:  Shima Shahbaz; Lai Xu; Mohammed Osman; Wendy Sligl; Justin Shields; Michael Joyce; D Lorne Tyrrell; Olaide Oyegbami; Shokrollah Elahi
Journal:  Stem Cell Reports       Date:  2021-05-11       Impact factor: 7.765

9.  IL-6 and Other Biomarkers associated with Poor Prognosis in a Cohort of Hospitalized Patients with COVID-19 in Madrid.

Authors:  Encarnación Donoso-Navarro; Ignacio Arribas Gómez; Francisco A Bernabeu-Andreu
Journal:  Biomark Insights       Date:  2021-05-24

Review 10.  COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development.

Authors:  Joowon Yim; Hee Hyun Lim; Youngjoo Kwon
Journal:  Arch Pharm Res       Date:  2021-05-28       Impact factor: 6.010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.